Increasing access to CAR-T therapy: a case study of an academic hospital's alternative innovation model

Adrián Alonso Ruiz; Erika Shinabargar; Iulia Slovenski; Kaitlin Large; Marcela Vieira; Suerie Moon

doi:10.1186/s13023-026-04320-7

Increasing access to CAR-T therapy: a case study of an academic hospital's alternative innovation model

Orphanet J Rare Dis. 2026 Apr 10. doi: 10.1186/s13023-026-04320-7. Online ahead of print.

Authors

Adrián Alonso Ruiz¹, Erika Shinabargar², Iulia Slovenski², Kaitlin Large², Marcela Vieira², Suerie Moon²

Affiliations

¹ Global Health Centre, Graduate Institute of International and Development Studies, Chem. Eugène-Rigot 2, Genève, 1202, Switzerland. adrian.ruiz@graduateinstitute.ch.
² Global Health Centre, Graduate Institute of International and Development Studies, Chem. Eugène-Rigot 2, Genève, 1202, Switzerland.

PMID: 41964091
DOI: 10.1186/s13023-026-04320-7

No abstract available

Keywords: Academic development; Access to medicines; Acute lymphoblastic leukemia; Advance therapy medicinal products; Advanced therapies; Alternative innovation models; CAR-T therapies; Hospital exemption; Orphan drugs; Pharmaceutical innovation.

Grants and funding

179842/Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung